Supernus SUPN
NASDAQ SUPN
$29.28 +0.53 (+1.86%)
As of: Nov 11, 2026 · 11:21 AM EST

Supernus (SUPN) Long-Term Investments (2023 - 2026)

Updated

Analysis

Supernus (SUPN) Long-Term Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Supernus 3.39 Bn 2.50 Bn 305.00 Mn 27.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.00 Mn
Jun 30, 2026 27.00 Mn
Mar 31, 2026 27.00 Mn
Dec 31, 2025 28.00 Mn
Sep 30, 2025 28.00 Mn
Jun 30, 2025 27.00 Mn
Mar 31, 2025 27.00 Mn
Dec 31, 2024 27.00 Mn
Dec 31, 2023 41.00 Mn
API Access

Supernus Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=SUPN&period=max&api_key=YOUR_API_KEY